There are 2846 resources available
Drugging KRAS in CRC: where do we stand?
Presenter: Rodrigo Dienstmann
Session: Are novel immunotherapeutics and targeted treatments going to transform the management of CRC?
Resources:
Slides
Webcast
The role of B cell/TLS
Presenter: Catherine Sautes-Fridman
Session: How the tumour microenvironment affects outcome and therapy response?
Resources:
Slides
Webcast
Acral melanoma
Presenter: Matteo Carlino
Session: Advances in non-cutaneous melanoma
Resources:
Slides
Webcast
The impact of COVID-19 on surgery
Presenter: Francoise Rimareix
Session: The impact of COVID-19 on patients with cancer: Lessons learnt and pathway for the future
Resources:
Slides
Webcast
Invited Discussant 277O and 278O
Presenter: Giuseppe Minniti
Session: Proffered Paper session: CNS tumours
Resources:
Slides
Webcast
Advocating for patients with ultra-rare cancer
Presenter: Hugh Leonard
Session: Ultra-rare sarcoma: Navigating an endless sea
Resources:
Slides
Webcast
Long term follow-up on single arm registration studies: what have we learned?
Presenter: Bishal Gyawali
Session: 5-year impact of new registered indications on the ESMO-MCBS
Resources:
Slides
Webcast
518O - Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation
Presenter: Amit Oza
Session: Proffered Paper session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Clinical development of next generation DDR agents for molecularly-selected tumours
Presenter: Timothy Yap
Session: Exploiting synthetic lethality: The next generation
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Using molecular data that impacts clinical practice
Resources:
Webcast